The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth <i>In Vivo</i> and Potentiates RadiotherapyKatrine Ingelshed, Saikiran K. Sedimbi|Cancer Research Communications|2022Cited by 14
MDM2/MDMX inhibition by Sulanemadlin synergizes with anti-Programmed Death 1 immunotherapy in wild-type p53 tumorsKatrine Ingelshed, Diana Spiegelberg|iScience|2024Cited by 14